G. dos Santos Clemente
2018: MSc in Biological Science (University of Hull, UK);
2016: PhD student at the The University Medical Center of Groningen;
2016: Good Laboratory Practice (GLP), Good Manufacturing Practice (GMP), and ICH Good Clinical Practice (GCP) accreditation by the Faculty of Pharmaceutical Medicine of the Royal College of Physicians, UK;
2016: Postgraduation in Research Training (University of Hull, UK);
2013: Radiation Protection Supervisor certification by the English Public Health department, UK;
2011-2013: Master in Nuclear Medicine, specialisation in Radiopharmacy (Lisbon School of Health Technology - ESTeSL, Portugal);
2011: FELASA category C accredited course for Coordinator Researcher for the practice of animal experimentation (Institute of Molecular and Cell Biology, Porto - IBMC, Portugal);
2006-2008: Postgraduation in Biomedical Inorganic Chemistry: Diagnostic and Therapy Applications (University of Lisbon Science Faculty - FCUL, Portugal);
2002-2006: Nuclear Medicine Technology BSc (Lisbon School of Health Technology - ESTeSL, Portugal).
2012-2016: Radiochemistry research technician (University of Hull, UK);
2009-2012: Nuclear medicine and radiopharmacy technician (Institute of Nuclear Sciences Applied to Health - ICNAS, Portugal);
2007-2008: Biomedical Inorganic Chemistry trainee (Nuclear and Technological Institute - ITN, Portugal).
|Last modified:||31 October 2018 3.14 p.m.|